Related Experiment Video
Updated: May 10, 2026
07:14
Virtual Agent for Real-Time Motivational Interviewing by Integrating Adaptive Nonverbal Behavior and Language Models
Published on: December 23, 2025
Motivational interviewing: a tool for increasing psychotropic medication adherence for youth
Vanya Hamrin1, Teena M McGuinness
1Vanderbilt University School of Nursing, Tennessee, USA.
Summary
Nonadherence to psychotropic medications in youth leads to severe outcomes. Motivational interviewing (MI) shows promise in improving medication adherence and reducing suicidal behavior in adolescents with mental health conditions.
Area of Science:
- Child and Adolescent Psychiatry
- Behavioral Psychology
- Clinical Psychology
Background:
- Nonadherence to psychotropic medications is prevalent in over 50% of youth with mental health conditions.
- Consequences of nonadherence include poor academic performance, prolonged illness, increased psychopathology, and suicide attempts.
- Psychotropic medication adherence is critical for improved psychiatric functioning and reduced suicidal behavior.
Purpose of the Study:
- To review literature on motivational interviewing (MI) for improving treatment adherence in children and adolescents.
- To explore the potential of MI in addressing medication nonadherence in youth.
- To provide practical examples of MI implementation for adolescents.
Main Methods:
- Literature review examining motivational interviewing (MI) interventions.
- Analysis of studies focusing on treatment adherence in pediatric populations.
- Case example illustrating MI techniques for youth.
Main Results:
- Motivational interviewing (MI) demonstrates significant potential to enhance psychiatric medication adherence in adolescents.
- Medication adherence is linked to improved psychiatric outcomes and a 50% reduction in suicidal behavior.
- MI can be effectively implemented to support youth in adhering to treatment plans.
Conclusions:
- Motivational interviewing (MI) is a promising intervention for improving psychotropic medication adherence in children and adolescents.
- Addressing nonadherence is crucial for mitigating severe psychiatric outcomes and enhancing treatment efficacy.
- Further research and implementation of MI are recommended to support youth mental health treatment.
Related Concept Videos
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:26Modeling in Therapy
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...